活性分子抑制剂-Amadis Chemical

图片	名称及描述
	(Z)-2-(3-((4-氯苄基)氧基)亚苄基)-6,7-二氢-2H-咪唑并[2,1-b][1,3]噻嗪-3(5H)-酮 PSB-CB5 A10136641627710-30-8 98%	Detail
	6-乙酰基-8-环戊基-5-甲基-2-((5-(哌啶-4-基)吡啶-2-基)氨基)吡啶并[2,3-d]嘧啶-7(8H)-酮 Dalpiciclib A10138281637781-04-4 98%	Detail
	Vonlerolizumab Vonlerolizumab A10138521638935-72-4 97%	Detail
	(2'S)-3-氯-4-((3,5-二氟吡啶-2-基)甲氧基)-2'-(2-(2-羟基丙烷-2-基)嘧啶-4-基)-5',6-二甲基-2H-[1,4'-联吡啶]-2-酮 Zunsemetinib A10138801640282-42-3 97%	Detail
	Velufenacin Velufenacin A10139811648737-78-3 97%	Detail
	替诺福韦二磷酸 Tenofovir Diphosphate A1014065166403-66-3 97%	Detail
	TGP-377 TGP-377 A101412816752-89-9 97%	Detail
	Vofopitant dihydrochloride Vofopitant dihydrochloride A1014182168266-51-1 97%	Detail
	2-(5-苯基-1H-吲哚-3-基)乙酸 5-Ph-IAA A1014218168649-23-8 98%	Detail
	(S)-3-(4-(5-胍基戊酰胺基)苯基)-2-((S)-1-(苯基磺酰基)吡咯烷-2-甲酰胺基)丙酸 αvβ1 integrin-IN-1 A10142401689540-62-2 97%	Detail
	N-(4-羟基苯乙基)戊-4-炔酰胺 Alkyne-phenol A10142671694495-59-4 98%	Detail
	WYE-687 dihydrochloride WYE-687 dihydrochloride A10143251702364-87-1 97%	Detail
	Infliximab Infliximab A1014329170277-31-3 98%	Detail
	N-(5-(6-氟-8-((4-(2-羟基丙烷-2-基)哌啶-1-基)甲基)-2-吗啉基喹唑啉-4-基)-2-甲氧基吡啶-3-基)甲磺酰胺 Linperlisib A10143321702816-75-8 98%	Detail
	(((S)-1-羧基-5-((S)-3-(萘-2-基)-2-(反式-4-((2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基)甲基)环己烷-1-甲酰胺基)丙酰胺基)戊基)氨基甲酰基)-L-谷氨酸 Vipivotide tetraxetan A10143351702967-37-0 97%	Detail
	ML-00253764 hydrochloride ML-00253764 hydrochloride A10143651706524-94-8 98%	Detail
	(S)-1-氟-3-((2-(6-(甲基氨基)吡啶-3-基)喹啉-6-基)氧基)丙-2-醇 THK5351 A10143711707147-26-9 98%	Detail
	扎帕洛格 Zapalog A10143831708091-24-0 97%	Detail
	沙西妥珠单抗 Sacituzumab A10148171796566-95-4 95%	Detail
	Tyk2-IN-5 Tyk2-IN-5 A10148291797432-62-2 97%	Detail